Hepatic steatosis in obese Chinese children

International Journal of Obesity

Volumn 28, Issue 10, 2004, Pages 1257-1263

  Chan, D F Y ^a,b   Li, A M ^a   Chu, W C W ^a   Chan, M H M ^a   Wong, E M C ^a   Liu, E K H ^a   Chan, I H S ^a   Yin, J ^a   Lam, C W K ^a   Fok, T F ^a   Nelson, E A S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Children; Insulin resistance; Nonalcoholic steatohepatitis; Ultrasonography

Indexed keywords

ALANINE AMINOTRANSFERASE; GLUCOSE; INSULIN; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL ABUSE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CHILD; CHINESE; CHRONIC LIVER DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NONALCOHOLIC FATTY LIVER; OBESITY; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; SKINFOLD THICKNESS; ANTHROPOMETRY; BLOOD; CROSS-SECTIONAL STUDY; DISEASE COURSE; HOSPITALIZATION;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

ADOLESCENT; ALANINE TRANSAMINASE; ANTHROPOMETRY; BIOLOGICAL MARKERS; BODY MASS INDEX; CHILD; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; OBESITY; SEVERITY OF ILLNESS INDEX;

EID: 6044227998     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802734     Document Type: Article

References (33)

1. Stephen CH, tri HL, Stacey MA. Non alcoholic steatohepatitis. In: Textbook. Schiff's disease of the liver., 9th edn. Lippinott William & Wilkins: Philadelphia, PA; 2002. pp 1261-1289.
2. Clark JM, Brancati FL, Diehl AE. Nonalcoholic fatty liver disease: the most common cause of abnormal liver enzymes in the US population. Gastroenterology 2001; 120: A-65.
3. WHO. (1999) Obesity: preventing and managing the global epidemic: report of a WHO consultation WHO Technical Report Series; 894 the office of Publication. World Health Organization: Geneva, Switzerland.
4. Bellentani S, Saccoccio G, Masutti F, Saccoccio G, Tiribelli C. Prevalence of and risk factors for hepatic steatosis in northern Italy. Ann Intern Med 2000; 132: 112-117.
5. Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, Kral JG. Liver pathology and the metabolic syndrome X in severe Obesity. J Clin Endocrinol Metab 1999; 84: 1513-1517.
6. Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S, Goto M. Prevalence of fatty liver in general population of Okinawa, Japan. Jpn J Med 1988; 27: 142-149.
7. Tominaga K, Kurata JH, Chen YK, Fujimoto E, Miyagawa S, Abe I, Kusano Y. Prevalence fatty liver in Japanese children and relationship to obesity: an epidemiological ultrasonographic survey. Dig Dis Sci 1995; 40: 2002-2009.
8. Foster KJ, Dewbury KC, Griffith AH, Wright R. The accuracy of ultrasound in the detection of fatty infiltration of the liver. Br J Radiol 1980; 53: 440-442.
9. Franzese A, Vajro P, Argenziano A, Puzziello A, Iannucci MP, Saviano MC, Brunetti F, Rubino A. Liver involvement in obese children: ultrasonography and liver enzyme levels at diagnosis and during follow-up on an Italian population. Dig Dis Sci 1997; 42: 1428-1432.
10. Joseph AE, Saverymuttu SH, Al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parentchymal liver disease. Clin Radiol 1991; 43: 26-31.
11. Angelico F, Ben MD, Conti R, Francioso S, Feole K, Macciono D, Antonini TM, Alessandri C. Non-alcoholic liver disease: non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases. J Gastroenterol Hepatol 2003; 18: 588-594.
12. Knobler H, Schattner A, Zhornicki T, Malnick SDH, Keter D, Sokolovskaya N, Luric Y, Bass DD. Fatty liver-an additional and treatable feature of the insulin resistance syndrome. QJM 1999; 92: 73-79.
13. Malnick SDH, Beergabel M, Knoblker H. Non-alcoholic fatty liver: a common manifestation of a metabolic disorder. QJM 2003; 96: 699-709.
14. Day CP, James OFW. Steatohepatitis: a tale of two 'hits'? Gastroenterology 1998; 114: 842-845.
15. Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinicopathological correlates of pediatric non-alcoholic fatty liver disease. J Pediatr 2003; 143: 500-505.
16. Leung SS, Lau JT, Tse LY, Oppenheimer SJ. Weight for age and weight for height references for Hong Kong children from birth to 18years. J Paediatr Child Health 1996; 32: 103-109.
17. Tanner JM. Physical growth and development. In: Forfar JO, Arneil GC (eds) Textbook of paediatrics. Churchill Livingstone: Edinburgh; 1984. pp 304-305.
18. Durnin JVGA, Womersley J. Body fat assessed from total body density and Its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974; 32: 77-97.
19. Evans DJ, Hoffman RG, Kalkhoff RK, Kissebah AH. Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism 1984; 33: 68-75.
20. Valdez R, Seidell JC, Ahn YI, Weiss KM. A new index of abdominal adiposity as an indicator of risk for cardiovascular disease. A cross-population study. Int J Obes Relat Metab Disord 1993; 17: 77-82 Abstract-EMBASE.
21. Cole TJ, Bellizi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity: international survey. BMJ 2000; 320: 1240-1243.
22. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
23. Conwell LS, Trost SG, Brown WJ, Batch JA. Indexes of insulin resistance and secretion in obese children and adolescents: a validation study. Diabetes Care 2004; 27: 314-319.
24. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Non-alcoholic steatohepatitis. Mayo Clinic experiences with a hitherto un-named disease. Mayo Clinic Proc 1980; 55: 434-438.
25. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, Mccullough AJ. Nonalcoholic fatty liver diease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-1419.
26. Giulio M, Mara B, Antonio ML, Morselli-Labate, Giampaolo B, Elisabetta B, Arthur J, McCullough, Gabriele F, Nazario M. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107: 450-455.
27. Sonsuz A, Basaranoglu M, Bilir M, Senturk H, Akin P. Hyperinsulinemia in nondiabetic, both obese and nonobese patients with non-alcoholic stratohepatitis. Am J Gastroenterol 2002; 97: 495.
28. Lee ZSK, Critchley JAJH, Ko GTC, Anderson PJ, Thomas GN, Young RP, Chan TY, Cockram CS, Tomlinson B, Chan JC. Obesity and cardiovascular risk factors in Hong Kong Chinese. Obes Rev 2002; 3: 173-182.
29. Steinberger J, Daniels SJ. Obesity, insulin resistance, diabetes, and cardiovascular risk in children. Circulation 2003; 107: 1448-1453.
30. Steinberger J, Moorehed C, Katch V, Rocchini AP. Relationship between insulin resistance and abnormal lipid profile in obese adolescents. J Pedatr 1995; 126: 690-695.
31. Kawasaki T, Hashimoto N, Kikuchi T, Takahashi H, Uchiyama M. The relationship between fatty liver and hyperinsulinaemia in obese Japanese children. J Pediatr Gastroenterol Nutr 1997; 24: 317-321.
32. Rashid M, Roberts EA. Nonalcoholic steatohepatitis in children. J Pedatri Gastroenterol Nutr 2000; 30: 48-53.
33. Leung SS, Lau JT, Tse LY, Oppenheimer SJ. Weight for age and weight for height references for Hong Kong children from birth to 18years. J Paediatr Child Health 1996; 32: 103-109.